Showing results (61-70 of 88) with videos related to
Sort By:
Pageof 9
Nature Cancer|February 5, 2022
An artificial intelligence framework integrating longitudinal electronic health records with real-world data enables continuous pan-cancer prognosticationOlivier Morin, Martin Vallières, Steve Braunstein, et al.Therapeutic Advances in Medical Oncology|March 26, 2026
Detection of actionable mutations in the cerebrospinal fluid and concordance/discordance with extracranial mutations in patients with metastatic breast cancer and leptomeningeal diseaseLaura A Huppert, Samantha Fisch, Lindy Her, et al.Journal of Neurosurgery. Pediatrics|April 11, 2020
Bringing high-grade arteriovenous malformations under control: clinical outcomes following multimodality treatment in childrenEthan A Winkler, Alex Lu, Ramin A Morshed, et al.International Journal of Radiation Oncology, Biology, Physics|April 9, 2019
Initial SRS for Patients With 5 to 15 Brain Metastases: Results of a Multi-Institutional ExperienceRyan T Hughes, Adrianna H Masters, Emory R McTyre, et al.Journal of Neurosurgery|October 25, 2023
Socioeconomic differences between medically and surgically treated prolactinomas: a retrospective review of 598 patientsRobert C Osorio, Alexander F Haddad, Danielle M Hart, et al.International Journal of Radiation Oncology, Biology, Physics|October 25, 2017
Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)Paul W Sperduto, Wen Jiang, Paul D Brown, et al.International Journal of Radiation Oncology, Biology, Physics|July 20, 2017
The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain MetastasesPaul W Sperduto, Wen Jiang, Paul D Brown, et al.Journal of Neurosurgery|November 26, 2022
Stereotactic radiosurgery and local control of brain metastases from triple-negative breast cancerRoman O Kowalchuk, Ajay Niranjan, Judith Hess, et al.Neuro-Oncology|June 3, 2022
Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539C Leland Rogers, Stephanie L Pugh, Michael A Vogelbaum, et al.JAMA Oncology|November 29, 2016
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.Pageof 9